News - Healixia

June 23, 2020

Coronavirus and the battle of the FAMHP: FAMHP facilitates and supports development of treatments and vaccines for COVID-19.

Source: FAMHP

Coronavirus en de strijd gevoerd door het FAGG: FAGG faciliteert en steunt ontwikkeling van behandelingen en vaccins voor COVID-19

Coronavirus et la lutte menée par l’AFMPS : l’AFMPS facilite et soutient le développement des traitements et vaccins COVID-19

June 23, 2020

Decreasing trend in the use of antibiotics in Belgian livestock farming continues

Source: FAMHP

Dalende trend van het antibioticagebruik in de Belgische veeteelt zet zich verder.

Nouvelle tendance à la baisse de la consommation d’antibiotiques dans l’élevage en Belgique

June 23, 2020

Coronavirus and the battle of the FAMHP: thorough work so that every patient can be treated

Source: FAMHP

Sinds het begin van de coronapandemie werken de teams van het FAGG keihard om de ziekenhuizen en apotheken te ondersteunen bij hun problemen met de bevoorrading van geneesmiddelen. Hieronder volgt een overzicht van de maatregelen die het FAGG heeft genomen om de geneesmiddelenvoorraad in België te garanderen.

Depuis le début de la pandémie de coronavirus, les équipes de l’AFMPS travaillent à un rythme intense pour soutenir les hôpitaux et les pharmacies face aux difficultés d’approvisionnement en médicaments. Voici un aperçu des mesures mises en place par l’AFMPS pour garantir les stocks de médicaments en Belgique.

June 23, 2020

Coronavirus : first COVID-19 vaccine trial authorized in Belgium

Source: FAMHP

The Federal Agency for Medicines and Health Products (FAMHP) has authorized the first clinical trial evaluating a vaccine against COVID-19 in Belgium. This is the candidate vaccine from the German biotech firm CureVac.

June 23, 2020

Reaction of the FAMHP to information in the media on serological tests

Source: FAMHP

Reactie van Xavier De Cuyper, administrateur-generaal van het FAGG.

Réaction de Xavier De Cuyper, administrateur général de l’AFMPS.

June 23, 2020

Coronavirus: the FAMHP is allowing an extension of the payment deadlines expiring before 01.07.2020.

Source: FAMHP

In the context of the coronavirus crisis, the FAMHP is extending all payment periods expiring before 01.07.2020 for all its customers.

June 2, 2020

EMA warns against use of unproven cell therapies

Heard from FAMHP

The Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) advises patients and citizens not to use unregulated cell therapies, which may be unsafe or ineffective.

June 2, 2020

Coronavirus: reminder of the risks of chloroquine and hydroxychloroquine

Heard from FAMHP

The FAMHP restates the risks linked to the use of chloroquine and hydroxychloroquine to treat COVID-19 following the publication of a retrospective analysis of a patient monitoring register in the medical journal The Lancet on 22 May 2020. The analysis did not highlight any benefits from these drugs in patients with COVID-19 and revealed adverse cardiovascular effects.

June 2, 2020

Coronavirus: updated guidelines for verifying the compliance and suitability of surgical face masks

Heard from FAMHP

The FAMHP has issued guidelines for checking the compliance and suitability of surgical face masks during the COVID-19 crisis. The guidelines are intended for companies, institutions and authorities that order, sell or use these masks.

June 2, 2020

Coronavirus: recommendations for replacing closed suction systems

Heard from FAMHP

The FAMHP reminds hospitals of the recommendations for replacing closed suction systems and offers temporary practical advice to help healthcare professionals waiting on a new stock of suction systems.